As on February 09, 2021, Heat Biologics Inc. (NASDAQ: HTBX) got off with the flyer as it spiked 49.82% to $12.54. During the day, the stock rose to $17.00 and sunk to $11.51 before settling in for the price of $8.37 at the close. Taking a more long-term approach, HTBX posted a 52-week range of $1.37-$30.10.
Meanwhile, its Annual Earning per share during the time was 49.50%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 33.20%. This publicly-traded company’s shares outstanding now amounts to $22.83 million, simultaneously with a float of $21.75 million. The organization now has a market capitalization sitting at $289.05 million. At the time of writing, stock’s 50-day Moving Average stood at $6.77, while the 200-day Moving Average is $8.06.
If we measure the efficiency of the company that is accounted for 36 employees. It has generated 84,697 per worker during the last fiscal year. Meanwhile, its income per employee was -556,044. The stock had 96.00 Receivables turnover and 0.05 Total Asset turnover. For the Profitability, stocks operating margin was -636.11 and Pretax Margin of -667.07.
Heat Biologics Inc. (HTBX) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Heat Biologics Inc.’s current insider ownership accounts for 4.40%, in contrast to 9.60% institutional ownership. According to the most recent insider trade that took place on Nov 12, this organization’s Director sold 103,304 shares at the rate of 1.03, making the entire transaction reach 106,403 in total value, affecting insider ownership by 0.
Heat Biologics Inc. (HTBX) Earnings and Revenue Records
If we go through the results of last quarter, which was made public on 9/29/2020, the company posted -$0.42 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -$0.23) by -$0.19. This company achieved a net margin of -656.51 while generating a return on equity of -91.28. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.36 per share during the current fiscal year.
Heat Biologics Inc.’s EPS increase for this current 12-month fiscal period is 33.20% and is forecasted to reach -1.19 in the upcoming year.
Heat Biologics Inc. (NASDAQ: HTBX) Trading Performance Indicators
Let’s observe the current performance indicators for Heat Biologics Inc. (HTBX). It’s Quick Ratio in the last reported quarter now stands at 31.30. The Stock has managed to achieve an average true range (ATR) of 1.21. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 67.22.
In the same vein, HTBX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.26, a figure that is expected to reach -0.41 in the next quarter, and analysts are predicting that it will be -1.19 at the market close of one year from today.
Technical Analysis of Heat Biologics Inc. (HTBX)
Through scrutinizing the latest numbers posted by the [Heat Biologics Inc., HTBX], it can be observed that its last 5-days Average volume of 15.24 million was better the volume of 4.21 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 61.29% While, its Average True Range was 1.59.
Raw Stochastic average of Heat Biologics Inc. (HTBX) in the period of the previous 100 days is set at 62.14%, which indicates a major rise in contrast to 57.28% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 197.33% that was higher than 104.39% volatility it exhibited in the past 100-days period.